Increased efflux rather than oxidation is the mechanism of glutathione depletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Biochem Biophys Res Commun. 1987 Oct 14;148(1):153-60. doi: 10.1016/0006-291x(87)91089-8.

Abstract

Incubation of isolated hepatocytes in the presence of either the parkinsonian-inducing compound 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or its putative toxic metabolite 1-methyl-4-phenylpyridinium ion (MPP+) led to a depletion of intracellular reduced glutathione (GSH), which was mostly recovered as glutathione disulfide (GSSG). However, both MPTP- and MPP+-induced glutathione perturbances were relatively unaffected by the prior inhibition of glutathione reductase with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), suggesting that intracellular oxidation was not the major mechanism involved in the GSH loss. Inclusion of cystine in the incubation mixtures revealed a time-dependent formation of cysteinyl glutathione (CySSG), indicating that an increased efflux was mostly responsible for the MPTP- and MPP+-induced GSH depletion. Therefore, the measurement of GSSG, which is apparently formed extracellularly, was not associated with oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Animals
  • Cells, Cultured
  • Cystine / pharmacology
  • Glutathione / analogs & derivatives
  • Glutathione / metabolism*
  • Glutathione Disulfide
  • Kinetics
  • Liver / drug effects
  • Liver / metabolism*
  • Male
  • Oxidation-Reduction
  • Pyridines / pharmacology*
  • Rats
  • Rats, Inbred Strains

Substances

  • Pyridines
  • Cystine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Glutathione
  • Glutathione Disulfide